Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-02-23

FDA Approved: TRIAMTERENE AND HYDROCHLOROTHIAZIDE — Original Application (Advagen Pharma Ltd)

View source ↗

Summary

Original approval of Triamterene and Hydrochlorothiazide (Advagen Pharma Ltd) under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Triamterene and Hydrochlorothiazide (Triamterene and hydrochlorothiazide)

Snippet

ORIG AP for TRIAMTERENE AND HYDROCHLOROTHIAZIDE (TRIAMTERENE AND HYDROCHLOROTHIAZIDE)